YSB

YSB AAQS

The The AAQS of YSB (9885.HK) as of Oct 17, 2026 is 3. In the previous year, The AAQS was 3.00 — a change of 0.00% (lower).

AAQS

3

YoY

0.00%

Last updated:

YSB has a current AAQS of 3.

A high AAQS can be seen as a positive indicator that the company is developing successfully.

Investors can assume that the company is on a good path to generate profits.

On the other hand, it is important to consider the AAQS of the stock YSB in comparison to the profits generated and other companies in the same industry. A high AAQS is not an absolute guarantee for a positive future. Only in this way can one get a complete picture of the company's performance.

In order to better assess the company's development, it is important to consider the AAQS in comparison to other companies in the same industry. In general, investors should always consider the AAQS of a company in connection with other fundamentals such as profit, EBIT, cash flow, and others in order to make an informed investment decision.

The YSB AAQS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

AAQS
Date
AAQS
Jan 1, 2020
3.00 CNY
Jan 1, 2021
3.00 CNY
Jan 1, 2022
3.00 CNY
Jan 1, 2023
3.00 CNY
Jan 1, 2024
3.00 CNY
Jan 1, 2025
3.00 CNY
The YSB AAQS history
YEARAAQSYoY
30.00%
30.00%
30.00%
30.00%
30.00%
3—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

YSB Stock analysis

What does YSB do? YSB Inc, listed on the Hong Kong Stock Exchange under ticker 9885.HK with ISIN KYG9879S1003, is a healthcare company headquartered in Guangzhou, China. The company went public on June 28, 2023, and currently employs 6,108 full-time staff. YSB Inc operates within the healthcare sector, focusing on the wholesale and retail of pharmaceuticals and healthcare products through both online and offline channels. The company provides an online platform enabling pharmaceutical distributors to sell their products. Additionally, it offers software-as-a-service (SaaS) solutions tailored for pharmacies, medical testing services for primary healthcare institutions, and sells smart unmanned pharmaceutical booths to third-party pharmacies. Maintenance and technical support services related to these booths are also provided. YSB Inc primarily serves the domestic Chinese market, with its operations centered in Guangzhou. The company's business model integrates digital solutions with physical healthcare distribution, aiming to streamline the supply chain for pharmaceutical products. Its online platform connects distributors with end-users, while its SaaS offerings support pharmacy operations. The firm's focus on smart unmanned pharmaceutical booths reflects its investment in innovative retail solutions within the healthcare sector. YSB Inc's services are designed to enhance efficiency and accessibility in the pharmaceutical distribution network across China. YSB is one of the most popular companies on Eulerpool.

Frequently Asked Questions about YSB stock

The AAQS of YSB is 3 in 2025.

On Eulerpool you can find the complete historical development of The AAQS YSB since 2006 – with annual values, charts, and detailed analysis.

The AAQS is a key figure developed by AlleAktien.

The AAQS is a key figure developed by AlleAktien.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — YSB

All Key Metrics — YSB